Deakin University, Geelong, VIC, Australia; Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, St Albans, VIC, Australia; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
Deakin University, Geelong, VIC, Australia; Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, St Albans, VIC, Australia; Institute for Health and Ageing, Australian Catholic University, Melbourne, VIC, Australia; Department of Medicine-Western Health, Melbourne Medical School, The University of Melbourne, St Albans, VIC, Australia; Australian Health Policy Collaboration, Melbourne, VIC, Australia.
Res Social Adm Pharm. 2018 Sep;14(9):846-850. doi: 10.1016/j.sapharm.2018.05.002. Epub 2018 May 9.
This study investigated associations between health literacy and use of anti-fracture medications in women with osteoporosis. Data were collected for women participating in the population-based Geelong Osteoporosis Study in Australia. Health literacy was ascertained using the Health Literacy Questionnaire (HLQ) and bone mineral density by dual x-ray absorptiometry. Self-reported current medications were classified using MIMS codes, with the category 'Agent affecting calcium and bone metabolism' indicating osteoporosis treatment. Analysis of Variance (p-value <0.1 indicating a trend) and Cohen's d effect sizes (ES [95%CI]) (categorised; Small >0.2-<0.5, Moderate >0.5-0.8, Large >0.8) were calculated for differences in HLQ scale scores between participants who did vs. did not self-report medication use. Among 620 women, 134 (21.6%) had osteoporosis, 14 (10.5%) of whom self-reported current anti-fracture medication use. Small/moderate ES indicated women taking medication had lower HLQ scores in scales 'Navigating the healthcare system', 'Ability to find health information' and 'Understand health information' (ES 0.36 [0.25-0.79], 0.41 [0.29-0.87] and 0.64 [0.54-1.03], respectively). A trend was observed (p = 0.09) for 'Understand health information' scale scores and utilisation of medication. These data suggest women with less confidence in their ability to find and understand health information may follow healthcare provider recommendations and utilise anti-fracture medications more readily.
本研究调查了健康素养与骨质疏松症女性使用抗骨折药物之间的关系。数据来自澳大利亚基于人群的 Geelong 骨质疏松症研究中的女性参与者。使用健康素养问卷 (HLQ) 和双能 X 线吸收法测定骨密度来确定健康素养。使用 MIMS 代码对自我报告的当前药物进行分类，其中“影响钙和骨骼代谢的药物”类别表示骨质疏松症治疗。使用方差分析 (p 值<0.1 表示趋势) 和 Cohen's d 效应大小 (95%CI) (分类; 小>0.2-<0.5，中>0.5-0.8，大>0.8) 计算参与者中自我报告使用药物与未使用药物的 HLQ 量表得分差异。在 620 名女性中，有 134 名 (21.6%)患有骨质疏松症，其中 14 名 (10.5%)自我报告目前正在使用抗骨折药物。小/中 ES 表明服用药物的女性在“导航医疗系统”、“寻找健康信息的能力”和“理解健康信息”量表中的 HLQ 评分较低 (ES 0.36 [0.25-0.79]、0.41 [0.29-0.87] 和 0.64 [0.54-1.03]，分别)。“理解健康信息”量表评分和药物使用存在趋势 (p=0.09)。这些数据表明，对自己找到和理解健康信息的能力信心不足的女性可能更倾向于听从医疗保健提供者的建议，更愿意使用抗骨折药物。
